Neurotrope Issues Statement On Eli Lilly's Solanezumab
Go back to Neurotrope Issues Statement On Eli Lilly's Solanezumab| Neurotrope, Inc. Common (NASDAQ: NTRP) | Delayed: 2.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.02 | 52 Week High | $0.80 | |||
| Open | $2.02 | 52 Week Low | $0.20 | |||
| Day High | $2.02 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $0.00 | |||
| Volume | 150 | |||||
